Each Snapshot is dated and refreshed when material changes occur. They are written for people who need the field laid out at a glance - not the latest move in it.
Treatment
5SnapshotNEWMay 8, 2026
Cardiac amyloidosis therapy reference (2026)
Reference snapshot of cardiac amyloidosis therapy across AL and ATTR types.
TreatmentDiagnosisPatient journey
SnapshotNEWMay 7, 2026
Lipid management therapy reference (2026)
Reference snapshot of lipid management therapy across foundational, add-on, and emerging tiers.
TreatmentBiomarkersDelivery
SnapshotNEWMay 5, 2026
HFrEF therapy reference (2026)
Reference snapshot of HFrEF therapy across the four-pillar standard, additional approved options, and emerging mechanism classes.
TreatmentBiomarkersPatient journey
SnapshotNEWMay 4, 2026
Type 1 diabetes therapy reference (2026)
Reference snapshot of T1D therapy across insulin delivery, disease modification, and beta-cell replacement.
TreatmentDeliveryDiagnosis
SnapshotApr 26, 2026industry-filing · FDA
ATTR cardiomyopathy treatment landscape, 2026 mid-year reference
Reference layout of the ATTR cardiomyopathy treatment landscape as of mid-2026: TTR stabilisers, TTR silencers, the diagnostic-pathway infrastructure, and the live commercial questions including diagnostic-pathway expansion and combination therapy.
TreatmentDiagnosisPipeline